Drug could offer weekly at-home injections, simp
Author: Michael
Mesoblast Limited, a global developer of allogene
ProMIS Neurosciences Inc.
NeuroEM Therapeutics, a clinical-stage biotechnol
Illumina, Inc.
GenSight Biologics S.A.
Fractyl Health, Inc.
A commentary issued on behalf of VentriPoint Diag
Alterity Therapeutics Ltd.
Correcting for extrinsic mortality suggests intr